BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Scope & Guideline

Unveiling the Complexities of Life: One Study at a Time

Introduction

Welcome to your portal for understanding BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0007-4888
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1956 to 2024
AbbreviationB EXP BIOL MED+ / Bull. Exp. Biol. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE focuses on the intersection of biological and medical research, emphasizing experimental studies that elucidate mechanisms underlying health and disease. The journal prioritizes innovative approaches and methodologies that contribute to advancements in biological sciences and their medical applications.
  1. Experimental Biology:
    The journal encompasses a wide range of experimental biology studies, including cellular and molecular biology, emphasizing the experimental methods used to elucidate biological processes.
  2. Medical Applications:
    Research published in the journal often focuses on the medical implications of biological findings, bridging the gap between laboratory research and clinical practice.
  3. Translational Research:
    A significant emphasis is placed on translational research, where findings from basic science are applied to develop new therapeutic strategies or diagnostics.
  4. Innovative Therapeutics:
    The journal publishes studies on novel therapeutic approaches, including drug development, gene therapy, and the use of biomaterials in medical applications.
  5. Pathophysiology:
    Research exploring the underlying mechanisms of diseases, including cancer, metabolic disorders, and infectious diseases, is a core focus, contributing to the understanding of disease progression and potential interventions.
The BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE has seen the emergence of several trending themes over recent years, reflecting contemporary challenges and advancements in biomedical research. These themes highlight the journal's responsiveness to the evolving landscape of health and disease research.
  1. Immunotherapy and Cancer Research:
    A significant increase in studies focused on immunotherapy approaches for cancer treatment, including the exploration of immune checkpoint inhibitors and novel vaccine strategies.
  2. Microbiome Research:
    Research on the gut microbiome and its implications for health and disease has rapidly expanded, indicating a growing recognition of the microbiome's role in various conditions.
  3. Regenerative Medicine:
    Emerging studies in regenerative medicine, particularly those involving stem cells and tissue engineering, suggest a trend towards innovative therapeutic strategies for repairing damaged tissues.
  4. Neurodegenerative Diseases:
    An increased focus on the mechanisms and potential therapies for neurodegenerative diseases, reflecting a growing public health concern and research interest in this area.
  5. Chronic Diseases and Metabolic Disorders:
    Research addressing chronic diseases, particularly metabolic disorders such as diabetes and obesity, is on the rise, highlighting the need for effective interventions and management strategies.

Declining or Waning

As the field of experimental biology and medicine evolves, certain research themes have shown a decline in publication frequency within the BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE. This shift may reflect changing priorities in research funding, advancements in technology, or a greater emphasis on specific areas of study.
  1. Traditional Pharmacology Studies:
    There appears to be a waning interest in traditional pharmacology studies, particularly those that do not incorporate novel methodologies or insights into drug mechanisms.
  2. Basic Animal Models:
    While animal models remain essential, there is a noticeable decrease in studies solely relying on basic animal models without a strong translational component or innovative applications.
  3. In Vitro Studies Without Clinical Relevance:
    Research focusing solely on in vitro studies that do not connect to clinical applications or translational potential has decreased, indicating a shift towards more integrative research.

Similar Journals

JOURNAL OF EXPERIMENTAL BIOLOGY

Innovative Research Shaping the Future of Biology
Publisher: COMPANY BIOLOGISTS LTDISSN: 0022-0949Frequency: 24 issues/year

JOURNAL OF EXPERIMENTAL BIOLOGY, published by COMPANY BIOLOGISTS LTD, stands as a cornerstone in the fields of Animal Science, Aquatic Science, Ecology, Insect Science, and Physiology. With a rich history dating back to 1945, this esteemed journal has continually provided a platform for high-quality research, evidenced by its impressive Q1 rankings across multiple categories in the 2023 Journal Citation Reports. Located in the United Kingdom, it serves an international audience, offering critical insights and advancements in various biological sciences. As a non-open access journal, it provides rigorous peer-reviewed articles that contribute profoundly to our understanding of biological processes and their implications. With an extensive reach among researchers, practitioners, and academia, the JOURNAL OF EXPERIMENTAL BIOLOGY is not only a repository of knowledge but also a catalyst for ongoing research and innovation in experimental biology.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Unraveling Complexities in Pathology and Beyond
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

Journal of Biological Research-Bollettino della Societa Italiana di Biologia Sperimentale

Transforming Biological Discoveries into Global Knowledge
Publisher: PAGEPRESS PUBLISSN: 1826-8838Frequency: 2 issues/year

The Journal of Biological Research-Bollettino della Societa Italiana di Biologia Sperimentale is a premier peer-reviewed journal published by PAGEPRESS PUBL, focusing on a diverse array of topics within the broad field of biological research. Established as an Open Access journal since 2009, it facilitates the dissemination of scientific knowledge across the globe, enhancing visibility and accessibility for researchers, professionals, and students alike. With an ISSN of 1826-8838 and E-ISSN 2284-0230, this journal serves as a platform for innovative studies in Biochemistry, Genetics, and Molecular Biology, with a growing emphasis on Plant Science. Although currently categorized in the Q4 quartile for various sub-disciplines, the journal is dedicated to fostering interdisciplinary collaboration and advancing research quality. The latest Scopus rankings indicate a burgeoning presence in the academic community, positioning itself at significant ranks within the fields it covers. With publication coverage extending from 2011 to 2024, the journal aims to push the frontiers of biological research while adapting to the evolving demands of the scientific community.

Animal Models and Experimental Medicine

Bridging laboratory insights with clinical breakthroughs.
Publisher: WILEYISSN: 2096-5451Frequency: 6 issues/year

Animal Models and Experimental Medicine is a prestigious open-access journal published by WILEY that has been a significant contribution to the field of biomedical research since its inception in 2018. Focusing on the role of animal models in the exploration of experimental medicine, the journal has garnered attention for its rigorous peer-reviewed articles that bridge laboratory research with clinical applications. The journal currently holds impressive quartile rankings, including Q1 in Medical Laboratory Technology, Veterinary (miscellaneous), and strong standings across various other categories, reflecting its reputable position within the Scopus rankings. With a commitment to disseminating high-quality research that advances knowledge and practice in veterinary and medical sciences, Animal Models and Experimental Medicine offers a platform for researchers, professionals, and students to contribute to and stay informed about pivotal developments in the field. As an open-access journal, it ensures accessibility, encouraging a wider readership and fostering collaboration among the scientific community.

Quantitative Biology

Integrating Data and Biology for Enhanced Understanding
Publisher: WILEYISSN: 2095-4689Frequency: 4 issues/year

Quantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.

Acta Naturae

Driving Innovation in Life Sciences Research
Publisher: RUSSIAN FEDERATION AGENCY SCIENCE & INNOVATIONISSN: 2075-8251Frequency: 4 issues/year

Acta Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.

Frontiers in Bioscience-Landmark

Uncovering Landmark Research in Life Sciences
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

BioImpacts

Championing open access to transformative scientific findings.
Publisher: TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICESISSN: 2228-5652Frequency: 4 issues/year

BioImpacts, an esteemed journal published by Tabriz University of Medical Sciences & Health Services, is a prominent platform dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Medicine, and Pharmaceutical Science. Established in 2011, this Open Access journal ensures that vital research findings are freely accessible to the global academic community. With an impressive presence in the Scopus database, BioImpacts currently holds a Q2 quartile ranking in its respective categories, reflecting its contribution to scientific discourse and its importance as a critical resource for researchers and practitioners alike. The journal's dynamic scope encompasses a wide range of topics, highlighting innovative research that addresses contemporary challenges in health and disease. Operating out of Tabriz, Iran, BioImpacts is committed to fostering interdisciplinary collaboration and knowledge dissemination through their dedicated publication efforts, which span from 2011 to 2024. Researchers, professionals, and students are encouraged to explore the rich content and cutting-edge studies presented in this journal, making it an indispensable resource in the scientific community.

Biomedical Research and Therapy

Transforming research into impactful therapies for tomorrow.
Publisher: BIOMEDPRESSISSN: 2198-4093Frequency: 12 issues/year

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.

BMB Reports

Fostering Dialogue in Biochemical Innovation
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.